Emmaus Life Sciences Buy Hold or Sell Recommendation

EMMADelisted Stock  USD 0.13  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Emmaus Life Sciences is 'Not Rated'. Macroaxis provides Emmaus Life buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EMMA positions. The advice algorithm takes into account all of Emmaus Life's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Emmaus Life's buy or sell advice are summarized below:
Real Value
0.1
Hype Value
0.13
Market Value
0.13
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Emmaus Life Sciences given historical horizon and risk tolerance towards Emmaus Life. When Macroaxis issues a 'buy' or 'sell' recommendation for Emmaus Life Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population.
In addition, we conduct extensive research on individual companies such as Emmaus and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Emmaus Life Sciences. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Execute Emmaus Life Buy or Sell Advice

The Emmaus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Emmaus Life Sciences. Macroaxis does not own or have any residual interests in Emmaus Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Emmaus Life's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Emmaus LifeBuy Emmaus Life
Not Rated
For the selected time horizon Emmaus Life Sciences has a Risk Adjusted Performance of 0.0457, Jensen Alpha of 0.8854, Total Risk Alpha of (1.00), Sortino Ratio of 0.0536 and Treynor Ratio of 3.85
We provide trade advice to complement the prevailing expert consensus on Emmaus Life Sciences. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Emmaus Life is not overpriced, please confirm all Emmaus Life Sciences fundamentals, including its price to sales, cash per share, short ratio, as well as the relationship between the ebitda and current ratio . As Emmaus Life Sciences appears to be a penny stock we also advise to verify its price to sales numbers.

Emmaus Life Trading Alerts and Improvement Suggestions

Emmaus Life Sciences is not yet fully synchronised with the market data
Emmaus Life Sciences has some characteristics of a very speculative penny stock
Emmaus Life Sciences has a very high chance of going through financial distress in the upcoming years
The company currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M.
Emmaus Life Sciences currently holds about 982 K in cash with (1.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 39.0% of the company shares are held by company insiders

Emmaus Life Returns Distribution Density

The distribution of Emmaus Life's historical returns is an attempt to chart the uncertainty of Emmaus Life's future price movements. The chart of the probability distribution of Emmaus Life daily returns describes the distribution of returns around its average expected value. We use Emmaus Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Emmaus Life returns is essential to provide solid investment advice for Emmaus Life.
Mean Return
0.91
Value At Risk
-16.67
Potential Upside
21.43
Standard Deviation
15.47
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Emmaus Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Emmaus Life Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Emmaus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Emmaus Life Buy or Sell Advice

When is the right time to buy or sell Emmaus Life Sciences? Buying financial instruments such as Emmaus OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Emmaus Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Defense Thematic Idea Now

Defense
Defense Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Defense theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Defense Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Emmaus OTC Stock

If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Correlations
Find global opportunities by holding instruments from different markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges